EPCAM and cholangiocarcinoma: Furthermore, AnnexinV+EpCAM+ASGPR1+ tumor-associated microparticles (taMPs) were significantly elevated in the serum of CCA patients and demonstrated diagnostic capability with both sensitivity and specificity exceeding 78% (75).